NOVARTIS AG (NVS) [Rocket]

Date Filed	Type	Description
02/04/2022	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/19/2020	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018	SC 13G	NOVARTIS AG reports a 7.2% stake in resTORbio, Inc.
02/01/2018	SC 13D	NOVARTIS AG reports a 98.7% stake in Advanced Accelerator Applications S.A.
12/19/2017	SC 13G/A	NOVARTIS AG reports a 4.1% stake in Aduro Biotech, Inc.
11/28/2017	SC 13D/A	NOVARTIS AG reports a 4.4% stake in Arrowhead Research Corporation
09/05/2017	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/30/2016	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
08/10/2016	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
02/11/2013	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
08/10/2012	SC 13D/A	NOVARTIS AG reports a 25.5% stake in Idenix Pharmaceuticals, Inc.
12/15/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/20/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
02/07/2011	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
12/15/2010	SC 13D/A	ALCON INC reports a 76.2% stake in Alcon, Inc.
08/30/2010	SC 13D/A	ALCON INC reports a 76.6% stake in Alcon, Inc.
06/18/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
02/16/2010	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
01/04/2010	SC 13D/A	ALCON INC reports a 24.8% stake in Alcon, Inc.
05/20/2009	SC 13D/A	NOVARTIS AG reports a 53% stake in Idenix Pharmaceuticals, Inc.
02/09/2009	SC 13G/A	Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]